1.
Aslonov I.F. IMPACT OF COMORBID CONDITIONS ON THE DEVELOPMENT OF NEPHROTOXICITY IN PATIENTS RECEIVING ANTI-TUBERCULOSIS THERAPY. CAJM. 2026;1(11):240-245. Accessed November 18, 2026. https://journals.tnmu.uz/index.php/cajm/article/view/3413